AutoGenomics files for a $65 million IPO

By
A A A

AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, filed on Thursday with the SEC to raise up to $65 million in an initial public offering. The Vista, CA-based company, which was founded in 1999 and booked $13 million in sales for the 12 months ended 6/30/2012, plans to list on the NASDAQ under the symbol AGMX. Leerink Swann is the lead bookrunner on the deal. No pricing terms were disclosed.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: AGMX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Why Bankers Are Dishonest
Why Bankers Are Dishonest           

Stocks

Referenced

Most Active by Volume

61,239,507
  • $35.95 ▲ 4.66%
52,285,072
  • $39.92 ▼ 2.49%
48,647,433
  • $17 ▼ 0.35%
41,081,140
  • $9.71 ▲ 2.32%
38,716,456
  • $116.31 ▲ 1.43%
35,895,170
  • $109.82 ▲ 0.92%
28,527,465
  • $8.98 ▲ 2.39%
28,391,104
  • $8.69 ▲ 1.40%
As of 11/20/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com